Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis
暂无分享,去创建一个
H. Nakshatri | M. Koizumi | H. Yokota | N. Matsuura | S. Na | Jiliang Li | Kazumasa Minami | Bai-Yan Li | Q. Wan | Yukun Yin | Andy B. Chen | Yang Liu | Shengzhi Liu | Liangying Gan | Aihua Xu | Qiaoqiao Wan
[1] A. I. Nash. Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs , 2017, Journal of Chemical Neuroanatomy.
[2] M. von Knebel Doeberitz,et al. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. , 2016, Gastroenterology.
[3] A. Jemal,et al. Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[4] S. Fox,et al. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer , 2016, Oncogene.
[5] A. Ghannam,et al. Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa , 2016, Cancer Cell International.
[6] Fanxin Long,et al. Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse. , 2016, Bone.
[7] F. Durif,et al. Parkinson's disease: A risk factor for osteoporosis. , 2015, Joint, bone, spine : revue du rhumatisme.
[8] H. Yokota,et al. Suppressed invasive and migratory behaviors of SW1353 chondrosarcoma cells through the regulation of Src, Rac1 GTPase, and MMP13. , 2015, Cellular signalling.
[9] R. Harris,et al. Antihypertensive mechanisms of intra-renal dopamine , 2015, Current opinion in nephrology and hypertension.
[10] D. Chappard,et al. Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss , 2015, Journal of musculoskeletal & neuronal interactions.
[11] Stephen T. C. Wong,et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. , 2015, Cancer cell.
[12] A. Sudo,et al. In vitro and in silico analysis of an inhibitory mechanism of osteoclastogenesis by salubrinal and guanabenz. , 2015, Cellular signalling.
[13] Torben Ott,et al. Dopamine Receptors Differentially Enhance Rule Coding in Primate Prefrontal Cortex Neurons , 2014, Neuron.
[14] B. Levine,et al. Autosis and autophagic cell death: the dark side of autophagy , 2014, Cell Death and Differentiation.
[15] M. Koizumi,et al. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling. , 2014, International journal of oncology.
[16] M. El-Sibai,et al. Signaling networks of Rho GTPases in cell motility. , 2013, Cellular signalling.
[17] P. Houghton,et al. RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis , 2013, Molecular Cancer Therapeutics.
[18] T. Guise. Breast Cancer Bone Metastases: It’s All about the Neighborhood , 2013, Cell.
[19] H. Yokota,et al. Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha , 2013, Journal of Bone and Mineral Metabolism.
[20] C. Weihl. Monitoring Autophagy in the Treatment of Protein Aggregate Diseases: Steps Toward Identifying Autophagic Biomarkers , 2013, Neurotherapeutics.
[21] F. Saad,et al. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial , 2012, The Lancet.
[22] W. Gregory,et al. Breast-cancer adjuvant therapy with zoledronic acid. , 2011, The New England journal of medicine.
[23] Y. Martin. The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413 , 2011, International journal of medicinal chemistry.
[24] R. Gainetdinov,et al. The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.
[25] G. Mengod,et al. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment , 2010, Neuroscience.
[26] Paola Chiarugi,et al. Rac and Rho GTPases in cancer cell motility control , 2010, Cell Communication and Signaling.
[27] Jaw-Chyng L. Lue,et al. Novel method to quantify traction in a vitrectomy procedure , 2010, British Journal of Ophthalmology.
[28] S. Ott,et al. Histomorphometric measurements of bone turnover, mineralization, and volume. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[29] E. Waclawski. Osteonecrosis of the jaw and bisphosphonates , 2006, BMJ : British Medical Journal.
[30] L. Duck,et al. Osteonecrosis of the jaw and bisphosphonates. , 2005, The New England journal of medicine.
[31] Kazuro Furukawa,et al. Differential enhancing effects of alpha2,8-sialyltransferase on the cell proliferation and mobility. , 2005, International journal of oncology.
[32] G. Roche-Nagle,et al. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer , 2002, British Journal of Cancer.
[33] P. Greengard,et al. The neurobiology of dopamine signaling , 2002, European Psychiatry.
[34] T. Martin,et al. A novel orthotopic model of breast cancer metastasis to bone , 1999, Clinical & Experimental Metastasis.
[35] P S Goldman-Rakic,et al. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex , 1998, Synapse.
[36] B F Boyce,et al. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. , 1995, Cancer research.
[37] J. Kebabian,et al. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. , 1992, European journal of pharmacology.
[38] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] M. Olivé,et al. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.
[40] P. Ralph,et al. Functional macrophage cell lines transformed by abelson leukemia virus , 1978, Cell.
[41] M. Olivé,et al. Breast tumor cell lines from pleural effusions. , 1974, Journal of the National Cancer Institute.
[42] H. Soule,et al. A simplified method for passage and long-term growth of human mammary epithelial cells , 2007, In Vitro Cellular & Developmental Biology.
[43] F. Wouters,et al. Visualization of molecular activities inside living cells with fluorescent labels. , 2004, International review of cytology.
[44] Th. Förster. Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .